JP2022553309A5 - - Google Patents
Info
- Publication number
- JP2022553309A5 JP2022553309A5 JP2022523415A JP2022523415A JP2022553309A5 JP 2022553309 A5 JP2022553309 A5 JP 2022553309A5 JP 2022523415 A JP2022523415 A JP 2022523415A JP 2022523415 A JP2022523415 A JP 2022523415A JP 2022553309 A5 JP2022553309 A5 JP 2022553309A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- vector
- seq
- pharmaceutical composition
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962924338P | 2019-10-22 | 2019-10-22 | |
| US62/924,338 | 2019-10-22 | ||
| PCT/US2020/056862 WO2021081203A1 (en) | 2019-10-22 | 2020-10-22 | Adeno-associated virus (aav)vectors for the treatment of age-related macular degeneration and other ocular diseases and disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553309A JP2022553309A (ja) | 2022-12-22 |
| JP2022553309A5 true JP2022553309A5 (https=) | 2023-10-30 |
Family
ID=75586875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523415A Pending JP2022553309A (ja) | 2019-10-22 | 2020-10-22 | 加齢黄斑変性ならびに他の眼疾患および障害の治療のためのアデノ随伴ウイルス（ａａｖ）ベクター |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210123076A1 (https=) |
| EP (1) | EP4048321A4 (https=) |
| JP (1) | JP2022553309A (https=) |
| KR (1) | KR20230019062A (https=) |
| CN (1) | CN115175706A (https=) |
| AU (1) | AU2020371663A1 (https=) |
| CA (1) | CA3158517A1 (https=) |
| IL (1) | IL292379A (https=) |
| MX (1) | MX2022004770A (https=) |
| WO (1) | WO2021081203A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7745389B2 (en) * | 2005-02-14 | 2010-06-29 | University Of Iowa Research Foundation | Methods for treatment of age-related macular degeneration |
| CN101160412A (zh) * | 2005-02-14 | 2008-04-09 | 爱荷华大学研究基金会 | 治疗和诊断年龄相关性黄斑变性的方法和试剂 |
| WO2007127428A2 (en) * | 2006-04-28 | 2007-11-08 | University Of Florida Research Foundation, Inc. | Double-stranded/self-complementary vectors with a truncated cba promoter and methods of gene delivery |
| EP2479284B1 (en) * | 2006-07-13 | 2017-09-20 | University of Iowa Research Foundation | Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration |
| CN108291216B (zh) * | 2015-09-24 | 2022-09-16 | 宾夕法尼亚州大学信托人 | 用于治疗补体介导的疾病的组合物和方法 |
| WO2017114401A1 (zh) * | 2015-12-31 | 2017-07-06 | 江苏匡亚生物医药科技有限公司 | 具有补体调节活性的重组补体因子h-免疫球蛋白融合蛋白及其制备方法与应用 |
| GB201706808D0 (en) * | 2017-04-28 | 2017-06-14 | Univ Newcastle | Modified complement proteins and uses thereof |
| EP3697920A4 (en) * | 2017-10-20 | 2022-03-02 | Gemini Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION |
-
2020
- 2020-10-22 EP EP20879947.8A patent/EP4048321A4/en active Pending
- 2020-10-22 AU AU2020371663A patent/AU2020371663A1/en not_active Abandoned
- 2020-10-22 CA CA3158517A patent/CA3158517A1/en active Pending
- 2020-10-22 KR KR1020227017063A patent/KR20230019062A/ko not_active Ceased
- 2020-10-22 WO PCT/US2020/056862 patent/WO2021081203A1/en not_active Ceased
- 2020-10-22 CN CN202080089391.2A patent/CN115175706A/zh active Pending
- 2020-10-22 MX MX2022004770A patent/MX2022004770A/es unknown
- 2020-10-22 IL IL292379A patent/IL292379A/en unknown
- 2020-10-22 US US17/077,683 patent/US20210123076A1/en active Pending
- 2020-10-22 JP JP2022523415A patent/JP2022553309A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6994018B2 (ja) | 新規アデノ随伴ウイルスキャプシドタンパク質 | |
| JP6683397B2 (ja) | 昆虫細胞で産生される、さらに改善されたａａｖベクター | |
| Büeler | Adeno-associated viral vectors for gene transfer and gene therapy | |
| AU2019250249A1 (en) | Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases | |
| CN110606874B (zh) | 用于基因转移到细胞、器官和组织中的变异aav和组合物、方法及用途 | |
| US6329181B1 (en) | Helper functions for recombinant vector production | |
| JP2022508182A5 (https=) | ||
| JP2021003120A5 (https=) | ||
| HRP20231077T1 (hr) | Genska terapija za pigmentni retinitis | |
| JP2017509632A5 (https=) | ||
| JP2023519502A (ja) | Ａａｖ生成のための二重二官能基ベクター | |
| JP2022524434A5 (https=) | ||
| JP2022551744A5 (https=) | ||
| JP2021523702A5 (https=) | ||
| CA3158518A1 (en) | Triple function adeno-associated virus (aav)vectors for the treatment of c9orf72 associated diseases | |
| JP2022525302A5 (https=) | ||
| JP2017529395A5 (https=) | ||
| JP2022542828A5 (https=) | ||
| JP2023534026A (ja) | 多部分遺伝子送達のための組み換えアデノ随伴ウイルスベクター | |
| JP2023520763A5 (https=) | ||
| WO2023278305A1 (en) | Methods and compositions for tau reduction gene therapy | |
| JP2023542131A5 (https=) | ||
| JP2023515795A5 (https=) | ||
| US11821009B2 (en) | Genetic modification of the AAV capsid resulting in altered tropism and enhanced vector delivery | |
| IL323167A (en) | Method for producing recombinant AAV particle preparations |